Please login to the form below

Not currently logged in
Email:
Password:

Suzanne Gagnon joins Idis as CMO

She was formerly chief medical officer at Icon

Idis Suzanne GagnonIdis has appointed Dr Suzanne Gagnon as its first chief medical officer.

Dr Gagnon will lead global medical affairs at Idis, which specialises in partnering with pharma firms to support patient access to medicines.

She was most recently chief medical officer at neuroscience company NuPathe, prior to which she spent ten years as chief medical officer at the clinical research organisation (CRO) Icon,

During her time at Icon, she gained senior level experience in medical, regulatory and clinical research operations, overseeing a staff of 400 professionals across 10 global locations.

"Suzanne brings senior leadership to our team and a unique blend of industry expertise to our customers that will help guide development and implementation of programmes that balance stakeholder requirements and effectively address the needs of patients," said Natalie Douglas, CEO of Idis. 

In addition to her industry experience, Dr Gagnon is adjunct professor, pharmaceutical product development at West Chester University, Pennsylvania.

13th March 2013

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...
Data security
Concerns about data security are building a strong case for clinical mobility in EMEA
Electronic medical records have transformed the storage of sensitive information but how can the healthcare sector continue to protect patient and staff data?...
Mainimage2
The role of digital health technology tools in supporting medical adherence
How DHT-based digital interventions can help to support patients and improve adherence...